Strength
100 mg/1
Manufacturer
Dr. Reddy's Laboratories Inc.NDC
43598034490
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
5/21/2025
Active Ingredients
IMATINIB MESYLATEApproval Type
Generic (ANDA)
FDA Application
ANDA206547On Market Since
8/13/2018
Pharmacological Classes
Bcr-Abl Tyrosine Kinase Inhibitors
Cytochrome P450 2D6 Inhibitors
Cytochrome P450 3A4 Inhibitors
Kinase Inhibitor
Related Drugs
Same classification
SERTRALINE HCL 25 MG TABLET
Generic
00904692461•Major Pharmaceuticals
$0.0300
per EA
SERTRALINE HCL 25 MG TABLET
Generic
16714061101•NorthStar Rx LLC
$0.0300
per EA
SERTRALINE HCL 25 MG TABLET
Generic
16714061104•NorthStar Rx LLC
$0.0300
per EA
SERTRALINE HCL 25 MG TABLET
Generic
16714061105•NorthStar Rx LLC
$0.0300
per EA
SERTRALINE HCL 25 MG TABLET
Generic
16714061106•NorthStar Rx LLC
$0.0300
per EA
SERTRALINE HCL 25 MG TABLET
Generic
16729021515•Accord Healthcare Inc.
$0.0300
per EA
SERTRALINE HCL 25 MG TABLET
Generic
16729021516•Accord Healthcare Inc.
$0.0300
per EA
SERTRALINE HCL 25 MG TABLET
Generic
23155075705•Heritage Pharmaceuticals Inc.
$0.0300
per EA
SERTRALINE HCL 25 MG TABLET
Generic
23155075709•Heritage Pharmaceuticals Inc.
$0.0300
per EA
SERTRALINE HCL 25 MG TABLET
Generic
31722014505•Camber Pharmaceuticals Inc.
$0.0300
per EA